FLGT

FLGT Operating Cash Flow (Statement)

-$83.70MTTM · USD

Period ending:

FLGT FY Cash from OperationsUSD
FLGT FY Cash from Operations2014-12-31: -$4.40M2015-12-31: -$969.00K2016-12-31: $4.41M2017-12-31: $1.33M2018-12-31: -$675.00K2019-12-31: $5.52M2020-12-31: $140.63M2021-12-31: $538.58M2022-12-31: $253.52M2023-12-31: $27.00M2024-12-31: $21.06M2025-12-31: -$101.64M$538.58M-$101.64M
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

FLGT operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Fulgent Genetics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-101,638,000
21,060,000
27,003,000
253,520,000
538,577,000
140,628,000
5,517,000
-675,000
1,331,000
4,405,000
-969,000
-4,397,000

Compare operating cash flow (statement)

All FLGT financial metrics · FLGT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.